期刊
PHARMACOLOGY RESEARCH & PERSPECTIVES
卷 5, 期 4, 页码 -出版社
JOHN WILEY & SONS LTD
DOI: 10.1002/prp2.329
关键词
bile acid; Cholestatic disease; Farnesoid X receptor; FXR; homeostasis; obeticholic acid; OCA
资金
- Intercept Pharmaceuticals, Inc
Farnesoid X receptor (FXR) is a master regulator of bile acid homeostasis through transcriptional regulation of genes involved in bile acid synthesis and cellular membrane transport. Impairment of bile acid efflux due to cholangiopathies results in chronic cholestasis leading to abnormal elevation of intrahepatic and systemic bile acid levels. Obeticholic acid (OCA) is a potent and selective FXR agonist that is 100-fold more potent than the endogenous ligand chenodeoxycholic acid (CDCA). The effects of OCA on genes involved in bile acid homeostasis were investigated using sandwich-cultured human hepatocytes. Gene expression was determined by measuring mRNA levels. OCA dose-dependently increased fibroblast growth factor-19 (FGF-19) and small heterodimer partner (SHP) which, in turn, suppress mRNA levels of cholesterol 7-alpha-hydroxylase (CYP7A1), the rate-limiting enzyme for de novo synthesis of bile acids. Consistent with CYP7A1 suppression, total bile acid content was decreased by OCA (1 mu mol/L) to 42.7 +/- 20.5% relative to control. In addition to suppressing de novo bile acids synthesis, OCA significantly increased the mRNA levels of transporters involved in bile acid homeostasis. The bile salt excretory pump (BSEP), a canalicular efflux transporter, increased by 6.4 +/- 0.8-fold, and the basolateral efflux heterodimer transporters, organic solute transporter alpha (OST alpha) and OST beta increased by 6.4 +/- 0.2-fold and 42.9 +/- 7.9-fold, respectively. The upregulation of BSEP and OST alpha and OST beta, by OCA reduced the intracellular concentrations of d(8)-TCA, a model bile acid, to 39.6 +/- 8.9% relative to control. These data demonstrate that OCA does suppress bile acid synthesis and reduce hepatocellular bile acid levels, supporting the use of OCA to treat bile acid-induced toxicity observed in cholestatic diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据